Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDraganfly Investments Regulatory News (DRG)

  • There is currently no data for DRG

Half Yearly Report

22 Dec 2009 11:21

RNS Number : 5464E
Draganfly Investments Ltd
22 December 2009
 

Registration number 89889

Draganfly Investments Limited

Chairman's statement and interim results

for the period ended 31 October 2009

Interim Results for period from May 1st 2009 to October 31st 2009

Chairman's Statement

During the period under review net assets have fallen from 1.57 pence per share on 30th April 2009 to 1.4 pence per share on October 30th 2009, a decline of 11% compared with a 35% rally in the wider AIM market during the corresponding period. 

This underperformance primarily reflects the large proportion of remaining unquoted holdings within the portfolio, and also the performance of Sino Gas and Energy immediately prior to admission on the ASX market. 

Prior to flotation on the ASX in September 2009, Sino Gas and Energy announced a rights issue at AUS 25 cents per share, representing a 50% discount to the last private funding round and the prevailing holding value within the portfolio. This resulted in a significant reduction in holding value of £387,000. Since flotation, the shares have declined by a further 28%, despite the company providing regular market updates regarding drilling progress and further gas discoveries. Sino Gas and Energy appears on course to meet its target of proving out a reserve base of between 100 bcf and 150 bcf of gas by the end of 2010. Peer group comparisons suggest this should equate to a valuation of AUS $100m in contrast with the recent range of $24m-28m. We look forward to further company updates with confidence. 

Whilst the current share price performance of Sino Gas and Energy is disappointing, the listing represents a significant boost to the portfolio's liquidity and an unrealised uplift of 25% since the original investment was made.

Elsewhere within the quoted portfolio, our AIM holdings rose 42% during the period under review, reflecting a very strong performance from Sirius Exploration, the potash exploration and development company. Sirius has rapidly assembled a world-class portfolio of potash assets in North Dakota, USA, and in North East and North West Australia, and also stands at the forefront of pioneering research into Compressed Air Energy Storage (CAES) and Carbon Sequestration at a time when clean energy, and in particular Carbon Capture, take centre stage on the political agenda worldwide. Sirius Exploration shares were added to the portfolio at 2 pence per share, following which we have traded out of a proportion of the shareholding at average prices of 9 pence per share, providing a zero-cost entry point. We continue to hold the majority of the position and look forward to a very exciting 2010 for the company. We also continue to hold Rheochem, Iofina and Immedia, all of which are progressing well and continue to meet our investment criteria of either generating cash flow and profitability, or building the platform for future profits growth. We have traded Iofina and Rheochem during the period and have disposed of the position in Medicsight.

We currently have five quoted holdings:

Sino Gas and Energy

Immedia PLC

Iofina

Rheochem

Sirius Exploration

Amongst the unquoted holdings Finance Ireland has not reflected any change since the last reporting period. Microsaic Systems and Atlantic Healthcare continue to develop their businesses and we expect news of product commercialisation and funding in due course. Holding values for these investments remain unchanged as indeed for Continental Petroleum where we expect a resolution to the protracted process of extending the company's exploration license in early 2010.

We currently have four unquoted holdings:

Finance Ireland

Atlantic Healthcare

Continental Petroleum Limited

Microsaic Systems

We remain convinced that our portfolio carries significant re-rating potential, but company scale remains an issue that is under review. Your Board is considering various options to increase the scale of the company and looks forward to reporting on progress in the coming months.

May I take this opportunity to thank shareholders for their support and wish you all a Merry Christmas and Happy and successful New Year.

Mark Horrocks

Chairman

  

For further information please contact:

T Edward G Bayman +44 (0) 1534 787889

Dennis Edmonds +44 (0) 7796 338 372

Clive Carver

FinnCap (Nominated Adviser) +44 (0)20 7600 1658

  

Draganfly Investments Limited

Unaudited Profit and loss account

for the period ended 31 October 2009

 
 
 
Continuing Operations
 
 
 
Period End 31/10/09
 
Period End 31/10/08
 
Notes
 
£
 
£
Turnover
2
 
(62,885)
 
(593,180)
Administrative expenses
 
 
(124,261)
 
(128,049)
Operating loss
 
 
(187,146)
 
(721,229)
 
 
 
 
 
 
Other interest receivable and similar income
 
 
 
-
 
 
-
Interest payable and similar charges
 
 
 
-
 
 
(8,943)
Loss on ordinary activities
 
 
(187,146)
 
(730,172)
 
 
 
 
 
 
There are no recognised gains or losses other than those included in the profit and loss account.
 
 
 
 
 
 
 
 
 
 
 
 
Earnings/ loss per share -basic
 
 
 
 
 
Basic
 
 
(0.0016)
 
(0.0640)

Draganfly Investments Limited

Unaudited Balance sheet

as at 31 October 2009

 
 
31/10/09
31/10/08
 
Notes
£
£
£
£
 
 
 
 
 
 
Current assets
 
 
 
 
 
Debtors
3
7,556
 
20,904
 
Investments
 
1,552,742
 
2,118,000
 
Brokers cash account
 
48,286
 
-
 
 
 
1,608,584
 
2,138,904
 
 
 
 
 
 
 
Creditors: amounts falling due within one year
 
 
 
 
 
Creditors
4
(7,326)
 
(12,222)
 
Bank overdraft
 
-
 
(57,414)
 
 
 
(7,326)
 
(69,636)
 
 
 
 
 
 
 
Net assets
 
 
1,601,258
 
2,069,268
 
 
 
 
 
 
Capital and reserves
 
 
 
 
 
Called up share capital
 
 
1,142,270
 
1,142,270
Share premium account
 
 
1,980,303
 
1,980,303
Profit and loss account
 
 
(1,521,315)
 
(1,053,305)
Equity shareholders' funds
5
 
1,601,258
 
2,069,268
 
 
 
 
 
 

 

Draganfly Investments Limited

Unaudited Cash flow statement

for the period ended 31 October 2009

Notes

Period ended 31/10/09

Period ended 31/10/08

£

£

Reconciliation of operating loss to net

cash outflow from operating activities

Operating loss

(187,146)

(721,229)

Realised (gain) / loss on sale of investments

(133,282)

265,695

Unrealised loss /(profit) on revaluation of investments

196,167

339,594

(Increase) in debtors

1,814

(15,881)

(Decrease) / increase in general creditors

(6,534)

7,201

Net cash outflow from operating activities

(128,981)

(139,022)

Cash flow statement

Net cash outflow from operating activities

(128,981)

(139,022)

Returns on investments and servicing of finance

-

(8,943)

Capital expenditure and financial investment

161,373

274,599

Increase /(Decrease) in cash in the period

32,392

126,634

Increase /(Decrease) in cash in the period

32,392

126,634

Opening cash balance / (bank overdraft)

15,895

(184,048)

Closing cash balance / (bank overdraft)

48,286

(57,414)

Draganfly Investments Limited

Notes to the interim statements

for the period ended 31 October 2009

1 Accounting policies

Basis of preparation The financial statements are prepared in accordance with applicable UK accounting standards.

Investments In accordance with FRS 26, investments are designated as at fair value through profit or loss. Quoted investments are stated at mid-market prices at the balance sheet date. Unlisted investments are stated at 'price of recent investment', reflecting the early stage nature of the investment. The following considerations are used when calculating the 'price of recent investment': (i) Where the investment being valued was itself made recently, its cost will generally provide a good indication of fair value. (ii) Where there has been a recent investment by third parties, the price of that investment will provide a basis of the valuation. Where a fair value cannot be estimated reliably, the investment is reported at cost or the carrying value at the previous reporting date, unless there is evidence that the investment has since been impaired. Taxation The company has been granted exempt company status within the meaning of Article 123A of the Income Tax (Jersey) Law 1961 (as amended). The effect of such special status is that the company is treated as a non-resident company for the purposes of Jersey tax laws and is therefore exempt from Jersey income tax on its profits arising outside Jersey and, by concession, on bank deposit interest arising in Jersey (and from any obligation to withhold Jersey income tax from any interest or dividend payments made by it). This status is renewable on an annual basis upon payment of a fee to the Comptroller of Income Tax in Jersey, and it is the company's intention to maintain this status. Consequently, no provision for taxation, either current or deferred has been made in these financial statements.

2 Turnover Turnover is derived from its principal activity and includes dividends received from investments. It also includes realised and unrealised profits and losses on investments.

 

Draganfly Investments Limited

Notes to the interim statements

for the period ended 31 October 2009

3 Investments

The carrying value of investments is stated as follows:

Quoted

£

Unquoted

£

Total

£

Fair value of investments at 1 May 2009

357,687

1,419,293

1,776,980

Transfers

829,894

(829,894)

-

Costs of investment purchases in the period

75,000

90,394

165,394

Sale proceeds of investments sold in the period

(326,767)

-

(326,767)

935,814

679,793

1,615,607

Realised losses on sale of investments included in the profit and loss account

133,282

-

133,282

Unrealised change in fair value of investments held at 30 April 2009 included in the profit and loss account

(196,167)

-

(196,167)

(62,885)

-

(62,885)

Fair value of portfolio of investments at 31 October 2009

875,929

679,793

1,552,722

Millpath Limited (note 15)

-

20

20

Fair value of total investments at 31 October 2009

875,929

679,813

1,552,742

4 Creditors: amounts falling due within one year

31/10/2009

£

31/10/2008

£

Bank overdraft

-

57,414

Other creditors

7,326

12,222

7,326

69,636

 

Notes to the interim statements

for the period ended 31 October 2009

5 Reconciliation of Shareholders' funds

Profit and Loss Account

£

Called up Share Capital

£

Share Premium

Account

£

Total

£

As at 1st May 2009

(1,334,169)

1,142,270

1,980,303

1,788,404

Loss for the period

(187,146)

-

-

(187,146)

As at 31st October 2009

(1,521,315)

1,142,270

1,980,303

1,601,258

6 Earnings per share Basic earnings per share is calculated on the basis of loss for the period of £730,172 and 114,227,000 shares being the weighted average number of shares in issue during the trading period.

7 Dividends No dividends have been paid or proposed.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR PUGBUPUPBGGP
Date   Source Headline
8th Aug 20184:05 pmRNSNet Asset Value
25th Jul 20189:19 amRNSRelated Party Transaction - CLN of £60,000
12th Jul 20182:00 pmRNSChange of Adviser
1st Jun 20183:16 pmRNSTransaction Update
3rd May 20183:23 pmRNSNet Asset Value(s)
22nd Mar 20188:10 amRNSTransaction Update
22nd Mar 20187:30 amRNSSuspension - Draganfly Investments Limited
12th Mar 20187:00 amRNSFundraising
5th Mar 20184:20 pmRNSAppointment of Broker
2nd Feb 20183:58 pmRNSNet Asset Value(s)
13th Dec 20175:07 pmRNSHalf-year Report
24th Nov 201712:56 pmRNSResult of AGM
7th Nov 20175:11 pmRNSNet Asset Value(s)
3rd Nov 20175:16 pmRNSHolding(s) in Company
27th Oct 20177:00 amRNSFinal Results
23rd Oct 201710:37 amRNSHolding(s) in Company
21st Aug 20179:08 amRNSDirectors' Disclosures
9th Aug 20174:38 pmRNSNet Asset Value(s)
3rd Aug 20177:00 amRNSBoard Appointment
31st May 201710:25 amRNSGrant of Options
30th May 20174:02 pmRNSBoard Appointment
24th May 20178:30 amRNSHolding(s) in Company
23rd May 20171:04 pmRNSNet Asset Value(s)
8th May 20179:11 amRNSFundraising
12th Apr 201711:06 amRNSResult of EGM
21st Mar 20172:10 pmRNSUpdate and Notice of EGM
17th Feb 201711:03 amRNSNet Asset Value(s)
31st Jan 201711:51 amRNSInterim Results
23rd Nov 20163:36 pmRNSResult of AGM
7th Nov 20169:35 amRNSNet Asset Value(s)
28th Oct 20165:01 pmRNSNotice of AGM
26th Oct 20167:00 amRNSAnnual Results
7th Oct 20167:00 amRNSLoan agreement
23rd Sep 20164:37 pmRNSNet Asset Value(s)
22nd Sep 20164:00 pmRNSFundraise
19th Jul 201612:20 pmRNSHolding(s) in Company
14th Jul 201612:20 pmRNSGM Result and Fundraise Update
27th Jun 20168:37 amRNSNet Asset Value(s)
24th Jun 20167:00 amRNSNotice of GM
18th Mar 20163:50 pmRNSReplacement - Appointment of Broker
18th Mar 20161:02 pmRNSAppointment of Broker
5th Feb 20161:11 pmRNSNet Asset Value(s)
29th Jan 20162:29 pmRNSInterim Results
27th Nov 201511:48 amRNSResult of AGM
11th Nov 20157:00 amRNSNotice of AGM
6th Nov 201510:16 amRNSNet Asset Value(s)
30th Oct 20157:00 amRNSFinal Results
6th Aug 20152:58 pmRNSNet Asset Value(s)
15th Jul 20157:00 amRNSInvestment Manager
5th May 20153:07 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.